Now Enrolling*
Coming Soon
Anticipated Sites Opening in 2020**
* Please check with local site team regarding impact of COVID-19 on enrollment activities.
** As more sites are identified they will be added to this list.
We aim to open GBM AGILE in Canada, Europe, and China in 2020. We will keep this information as up to date as possible as information changes.
Please follow us on Twitter or Facebook and join our email list for updates.
A committed group of over 130 oncologists, statisticians, pathologists, neurosurgeons, imagers, advocates, and researchers from academia, industry and government met regularly as collaborative teams to shape the adaptive design and master protocol for GBM AGILE.
Director, Barrow Neurological Institute,
Chief of Pediatric Neurosurgery
Phoenix Children’s Hospital
Diane and Bruce Halle Endowed Chair
in Pediatric Neurosciences
Professor, Neurosurgery/ Child Health,
University of Arizona College of Medicine – Phoenix
Professor, Neurosurgery, Mayo Clinic
Associate Professor, Radiation Oncology,
Harvard Medical School
Disease Center Leader for Radiation Oncology,
Center for Neuro-Oncology,
Dana-Farber/Brigham and Women’s Cancer Center
Deputy Director for Regulatory Science,
Harvard/MIT Center for Regulatory Science
Life Science and Nanotechnology Consultant,
National Biomarker Development Alliance
Research Associate
National Biomarker Development Alliance
Arizona State University
Chief Executive Officer,
National Brain Tumor Society
Director of Pediatric Neuro-Oncology, Preston
Robert Tisch Brain Tumor Center at Duke
University Medical Center
President and Chief Operating Officer,
National Foundation for Cancer Research
Director, Transformative Healthcare Networks
National Biomarker Development Alliance
Co-Director, Complex Adaptive Systems Initiative
Professor, School of Life Sciences
Arizona State University
Distinguished Professor of Neurological Surgery
Brain Tumor Research Center
University of California, San Francisco
Founder & Senior Statistical Scientist,
Berry Consultants, LLC
Professor, Department of Biostatistics,
University of Texas, MD Anderson Cancer Center
Medical Director, Brain Science Program MRI Research Facility
Brown University
Associate Professor, Department of Diagnostic Imaging
Warren Alpert Medical School of Brown University
Chair, Department of Pathology
Magerstadt Professor of Pathology,
Professor of Pathology,
Feinberg School of Medicine,
Northwestern University
Neurosurgeon and Physician-scientist,
Memorial Sloan Kettering Cancer Center
Clinical Associate Professor
Pathology, School of Medical Sciences
Sydney Medical School, University of Sydney
Head of the Department of Neuropathology,
Royal Prince Alfred Hospital
Head of the Molecular Neuropathology Program,
Brain & Mind Research Institute
Co-Director, Multiple Sclerosis Research Australia Brain Bank
Professor; Director,
Computational Science and Informatics Core Program,
Complex Adaptive Systems Initiative,
School of Life Sciences,
Arizona State University
Director, Clinical Trial Strategy
Berry Consultants, LLC
Meyer Director of the Sandra
and Edward Meyer Cancer Center,
Weill Cornell Medical College/
Ronald P. Stanton Clinical Cancer Program,
New York-Presbyterian, Professor of Cancer Biology in Medicine
Director, Ludwig Institute for Cancer Research
Distinguished Professor, University of California, San Diego
Professor in Residence and Vice Chair of Neurological Surgery
Lai Wan Kan Endowed Chair
Director, Division of Neuro-Oncology
Program Leader, UCSF Comprehensive Cancer Center
Director, UCSF Neuro-Oncology Gordon Murray Caregiver Program
Associate Vice Chancellor and
Chief Innovation Officer, the University of Texas System
Chair, Department of Neurosurgery
Co-Director, Institute for the Neurosciences
Harvey W. Cushing Professor of Neurosurgery,
Harvard Medical School
Director, Neuro-Oncology Program
Professor, Neurology, David Geffen School of Medicine
University of California, Los Angeles
Vice President, Global Product Development Oncology, Pfizer
Director, Medical Neuro-Oncology,
Associate Professor, Department of Neurosurgery,
Huntsman Cancer Institute,
University of Utah
Chief Medical Officer,
National Biomarkers Development Alliance
Chief Medical Officer,
Complex Adaptive Systems Initiative
Professor, School of Life Sciences
Arizona State University
Director and Senior Statistical Scientist,
Berry Consultants, LLC
Chief Executive Officer,
ZIOPHARM Oncology
Chief Executive Officer and Director,
Biohaven Pharmaceuticals
Professor, Department of Neurosurgery,
Karen Osney Brownstein Endowed Chair in
Molecular Neuro-Oncology,
Director, Training Program in Translational Brain Tumor Research
University of California, San Francisco
Professor and Department Chair ad interim,
Department of Neuro-Oncology,
University of Texas, MD Anderson Cancer Center
Medical Oncologist,
Royal Melbourne Hospital
and the Peter MacCallum Cancer Centre
Associate Director, Cancer Trials Australia
Professor, Departments of Genomic
Medicine and Molecular & Cellular Oncology
University of Texas, MD Anderson Cancer Center
Assistant Professor, Radiology, Biomedical Physics,
and Bioengineering
UCLA Brain Tumor Imaging Laboratory
David Geffen School of Medicine,
University of California, Los Angeles
Director, Carol Franc Buck Breast Care Center
Professor, Surgery and Radiology
University of California, San Francisco
Director, Brain Tumor Center,
New York-Presbyterian Weill Cornell Medical Center
Associate Director, Translational Research,
Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine
Professor, Oncology
Consultant, Division of Medical Oncology,
Department of Oncology,
Mayo Clinic
Director, Clinical Trials Austin Health
Senior Clinical Research Fellow,
Tumour Targeting Laboratory
Olivia Newton-John Cancer Research Institute
Professor, Biostatistics and Research Methodology
Medicine, Sydney Medical School, University of Sydney
NHMRC Clinical Trials Centre
Assistant Professor of Neurology,
Massachusetts General Hospital
Professor, Radiology and Biomedical Physics
Executive Chief, Clinical Care, Department of Radiology
Chief of Radiology, UCLA Medical Center, Santa Monica
Chief of Santa Monica Multi-Specialty Radiology
Director of Coronary Artery Calcium Screening Program
Co-Director of Thoracic Research Imaging Laboratory
University of California, Los Angeles
Medical Writer and Owner,
Goldthwaite & Associates
Principal Consultant, Regulatory Pathfinders, LLC
Senior Statistical Scientist, Berry Consultants, LLC
Strategic Advisor, Myraqa, Illumina, Inc.
Clinical Trials Program Director,
NHMRC Clinical Trials Centre
University of Sydney
Elizabeth W. Gilloon Professor of Chemistry,
California Institute of Technology
Professor, Neurosurgery
Principle Investigator, Brain Tumor
Immunology and Immunotherapy Lab
University of Texas, MD Anderson Cancer Center
Co-leader, Glioblastoma Moon Shot
Founder and President, Syapse, Inc.
Head, Development Design Center, AbbVie
Associate Professor, Departments of Pathology,
Anatomical and Translational Molecular Pathology
University of Texas, MD Anderson Cancer Center
Professor, Department of Radiology and Biomedical Imaging
Director of the Breast Imaging Research Group
University of California, San Francisco
Chief Physician and Professor of Neurosurgery
Department of Neurosurgery
Beijing Tiantan Hospital
Associate Professor, Oncology
Clinical Lead, NHMRC Clinical Trials Centre
Sydney Medical School
University of Sydney, Australia
Professor, Department of Radiation Oncology
Chair, Department of Radiation Oncology
New York University Langone Health
Senior Director, Medical Sciences, Kyowa Kirin, Inc.-US.
Acting Chief Financial Officer, Jacana Energy
Professor and Director of Glioma Program,
Beijing Shijitan Hospital, China
Chair, Department of Neurosurgery
Professor, Department of Neurosurgery,
Director, Brain Tumor Program,
David Geffen School of Medicine, University of California, Los Angeles
Director of Brain Tumor Immunotherapy
Professor of Neurosurgery
Johns Hopkins University
Pathologist-in-Chief, Massachusetts General Hospital
Benjamin Castleman Professor of Pathology,
Harvard Medical School
Richard C. Schneider Collegiate Professor of Neurosurgery
Professor, Cell and Developmental Biology
University of Michigan
Department of Neurosurgery,
Peking Union Medical College Hospital
Head of Clinical Data Management,
NHMRC Clinical Trials Centre
University of Sydney
Associate Professor, School of Life Sciences
Arizona State University
Associate Professor, Department of Neurosurgery
Chinese PLA General Hospital
Department of Neurosurgery,
Sichuan University
Vice Chair for Research, Department of Neurology,
Evnin Family Chair in Neuro-Oncology,
Memorial Sloan Kettering Cancer Center
President and Chief Scientific Officer,
Ontario Brain Institute
Senior Staff Physician, Neurology
Henry Ford Health System
Professor, Pathology & Laboratory Medicine
and Molecular & Medical Pharmacology,
David Geffen School of Medicine
University of California, Los Angeles
Founder, Facilitation | Foresight | Strategy
Director, Biomedical Strategy & Knowledge
Development, Complex Adaptive Systems,
Professor of Practice, Ira A. Fulton Schools of
Engineering, Arizona State University
Margaret Hart Surbeck Distinguished Professor,
Department of Radiology and Biomedical Imaging
Co-Chair, Department of Bioengineering and Therapeutic Sciences
Director, Center for Non-Invasive Imaging and Metabolomics (CNIM)
and the Surbeck Laboratory of Advanced Imaging
University of California, San Francisco
Professor, Neurological Surgery
Director, UCSF Brain Tumor Immunotherapy Center
University of California, San Francisco
Director, Clinical Trial Science
Berry Consultants, LLC
Director, Brain Tumor Center; Albert C. Foster Chair,
American Cancer Society Research Professor
Memorial Sloan Kettering Cancer Center
Director, Software Solutions
Berry Consultants, LLC
President, Chief Executive Officer & Director,
ESSA Pharma, Inc.
Executive Assistant to Dr. Anna Barker,
National Biomarker Development Alliance,
Complex Adaptive Systems Initiative,
Arizona State University
Professor in Residence, Radiology, Section of Neuroradiology
Director, Brain Tumor Imaging
University of California, Los Angeles
Interim Chief Science Officer, NBDA
Co-Director, Complex Adaptive Systems
Regents’ Professor and Del E. Webb Professor
Health Innovation, Arizona State University
Professor in Residence, Neurological Surgery,
Charles B. Wilson MD Endowed Chair
Director, Translational Research in Neuro-Oncology
University of California, San Francisco
Associate Chief Physician,
Beijing Tian Tan Hospital,
Capital Medical University
Professor, Biostatistics,
Harvard T.H. Chan School of Public Health
Professor, Biostatistics and Computational Biology
Dana-Farber Cancer Institute
Clinical Director, Center for Neuro-Oncology
Dana-Farber Cancer Institute
Professor of Medicine, Harvard Medical School
Irving J. Sherman Research Professor
Professor, Neurosurgery
Johns Hopkins University
Senior Staff Specialist, Department of Medical Oncology,
Director, Parkville Cancer Clinical Trials Unit
Peter MacCallum Cancer Centre
Chief, Department of Neurosurgery
Professor of Surgery, Biomedical Engineering, Immunology, and Pathology
Duke University
Consultant, Department of Radiation Oncology
Professor, Department of Radiation Oncology
Mayo Clinic
Research Assistant
National Biomarker Development Alliance
Arizona State University
Professor of Clinical Epidemiology, University of Sydney
Director, NHMRC Clinical Trials Centre and Sydney
Catalyst Translational Research Centre
NHMRC Senior Principal Research Fellow
Medical Oncologist, Royal Prince Alfred Hospital & Chris O'Brien Lifehouse
President and Chief Scientific Officer, Caris Life Sciences
Founder of GreenBowl
Co-Founder SW/TCH Festival
Chief Executive Officer, Cure Brain Cancer Foundation
Executive Vice President for Research and Deputy Scientific Director
Ludwig Institute for Cancer Research
Professor of Radiology
Co-Director, Radiation Oncology and Imaging Program
Duke Comprehensive Cancer Institute
Assistant Professor, Department of Radiation Oncology, Division of Radiation Oncology
The University of Texas MD Anderson Cancer Center
Director, Mathematical Neuro-Oncology Laboratory at Mayo Clinic
Co-Director, Precision Neurotherapeutics Innovation Program at Mayo Clinic
Professor and Vice Chair of Research, Neurological Surgery at Mayo Clinic
Professor, Mathematics at Arizona State University
Adjunct Professor, Cancer and Cell Biology, TGen
Medical Director, Eli Lilly and Company
Senior Project Consultant,
National Biomarker Development Alliance
Leader, Breast Oncology Program
Associate Director, Applied Genomics Cancer Center
Professor of Laboratory Medicine
University of California, San Francisco
Director, Biospecimen Resource Program
University of California, San Francisco
Professor and Associate Director, Computational Biology
The Jackson Laboratory
Professor and Director, Laboratory of Genetics, Salk Institute for Biological Sciences
American Cancer Society Professor of Molecular Biology
Irwin and Joan Jacobs Chair in Exemplary Life Science
Chief Executive Officer, Accelerate Brain Cancer Cure
Director of Neurosurgery,
Peking Union Medical College Hospital
Chief Strategy Officer,
National Foundation for Cancer Research
Chief Operating Officer,
Asian Fund for Cancer Research
Assistant Professor, Neurology
University of Michigan Comprehensive Epilepsy Center
University of Michigan
Graphic Artist
National Biomarker Development Alliance
Professor and Chairman, Department of Neurology
University Hospital Zurich, Switzerland
Director, Center for Neuro-Oncology at Dana-Farber Cancer Institute
Institute Physician and Professor of Neurology
Harvard Medical School
Professor, Biological Engineering
Massachusetts Institute of Technology (MIT)
Professor and Chairman, Department of Neuro-oncology at the National Center for Tumor Diseases
Division Head of Neuro-Oncology at the German Cancer Research Center
Chairman, Neurology Clinic
University of Heidelberg
President of the Helmholtz Association
Chief Science Officer, American Brain Tumor Association
Consultant/Advisor, American Brain Tumor Association
Head of Clinical Development, Celgene
Department of Neuropathology,
Institute of Neurology,
Huashan Hospital of Fudan University
Henry S. Friedman Professor of Neuro-Oncology
Duke University
Department of Neurosurgery, Huashan Hospital
Fudan University, Shanghai, China
Associate Professor, Department of Integrative Medicine and Neurobiology
Fudan University, Shanghai, China
Chief, Department of Neurosurgery
Chinese PLA General Hospital
Professor, Department of Neuro-Oncology
University of Texas, MD Anderson Cancer Center
Director, Cancer Genomics and Precision Oncology at Wake Forest Baptist Medical Center
Professor, Virginia Tech-Wake Forest University
Co-Director, ISB/MDACC Genome Data Analysis Center
President and Director, United States Chinese Anti-Cancer Association, Inc.
Department of Neurosurgery, Huashan Hospital of Fudan University
Postdoctoral Research Fellow, Department of Microbiology and Immunology
Stanford University School of Medicine
Department of Neurosurgery,
Chinese PLA General Hospital, Beijing